Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00571402 · ClinicalTrials.gov registry record · Phase 1

Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder

A Phase 1 study of Bipolar Disorder, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
58
Enrollment target
2
Study locations

NCT00571402: Completed Phase 1 study of Bipolar Disorder, sponsored by University of California, Los Angeles.

NCT00571402 is a Phase 1 study of Bipolar Disorder that has completed, run by University of California, Los Angeles. The registered enrollment target is 58 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00571402, a Phase 1 study of Bipolar Disorder, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
58 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the effectiveness of family-focused psychoeducational treatment along with medication in treating adolescents with bipolar I disorder.

Conditions Studied

Bipolar Disorder

Interventions

  • BEHAVIORAL Family-focused therapy for adolescents
  • BEHAVIORAL Enhanced care

Study Locations (2)

Colorado

  • Department of Psychology, University of Colorado - Boulder

Pennsylvania

  • Child and Adolescent Bipolar Services Clinic - Pittsburgh

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2001-07
Est. Completion 2005-09
Phase Phase 1
University of California, Los Angeles

897 total trials

What the finished NCT00571402 record still lists

NCT00571402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family-focused therapy for adolescents is the first listed.

NCT00571402 reports a single indexed study location in Colorado, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00571402 about?

NCT00571402 is a clinical study titled "Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder". This study will evaluate the effectiveness of family-focused psychoeducational treatment along with medication in treating adolescents with bipolar I disorder.

What is the current status of trial NCT00571402?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2001-07. Estimated completion is 2005-09.

What conditions does trial NCT00571402 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT00571402?

The interventions under investigation include: Family-focused therapy for adolescents (BEHAVIORAL), Enhanced care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00571402?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00571402 being conducted?

This trial has 2 study locations across Colorado, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00571402's enrollment target sits among peer trials

58 97th of 162 higher than 66 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00571402, the US trial registry maintained by the National Library of Medicine. NCT00571402 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.